Blog December 17, 2019
Did you hear that the US House of Representatives passed H.R. 3, the Lower Drug Costs Now Act, a sweeping bill designed to lower drug prices? We detail the bill and what it could mean for life sciences companies in this week's edition of The Week That Was.
Blog December 13, 2019
A new study suggests we may be consuming more BPA than previously thought. Using a direct method to analyze metabolites paints a much clearer picture of BPA levels in our diets.
Blog December 12, 2019
When Amazon first bought the online pharmacy PillPack, in 2018, many began wondering about the precise nature of Amazon’s health care ambitions. At last, some customers are now experiencing Amazonian health care firsthand.
Blog December 9, 2019
Uber recently released a safety report and announced steps it plans to take to address sexual assault in ride shares and provide support for victims. We dig into their reputation repair campaign and how it’s impacting the competition in this week’s The Week That Was.
Blog December 4, 2019
In early November, thousands of people from around the world gathered together in Dubai to get first-hand access to a class of innovators designing solutions for a better world.
Blog November 27, 2019
The revolutionary look and feel of many modern clinical trials are exemplified by three new studies from a very powerful sponsor: Apple.
Blog November 25, 2019
A consortium of 300 powerful organizations have filed resolutions demanding research into the feasibility of tying drug pricing to senior executive incentive pay. Read about this and much more in this week’s edition of The Week That Was.
Blog November 22, 2019
Here’s one initiative that might inspire models of other mental health care: in Orleans, Indiana, one school is finding ways to get their students the care they need.
Blog November 21, 2019
The effects of space on the human body are still being researched, and in recent years we’ve discovered more about the effects. Loss of muscle mass, brittle bones, and behavioral issues due to isolation are just a few of the challenges astronauts face.
Blog November 18, 2019
How will the Institute for Clinical and Economic Review (ICER) reconcile the tug-of-war between the promise and uncertainty in valuing gene therapies? We dig into this and more in this week’s edition of The Week That Was.
Blog November 15, 2019
Recent headlines amplify anxiety among parents, but behavioral science provides tools to short-circuit these traps.
Blog November 11, 2019
It’s been a little over a year since the first crash of a Boeing 737 Max in Indonesia. We dig into how Boeing leaders are working to rebuild their reputation and more in this week’s edition of The Week That Was.
Blog November 8, 2019
Facebook is launching Preventive Health, a program designed to make its feed-scrollers the world over more health-conscious, especially when it comes to cancer, heart disease, and the flu.
Blog November 5, 2019
On Wednesday, the House Energy & Commerce Committee held a hearing on safeguarding pharmaceutical supply chains in a global economy, and the discussion included something for everyone. Read about the hearing in this week’s edition of The Week That Was.
Blog October 31, 2019
You may know Bose for their cutting-edge speakers and audio tools, but soon they’ll be known for something else. Adding itself to the list of out-of-industry companies breaking into healthcare, Bose makes a big leap with FDA approval for its direct-to-consumer hearing aid.
Blog October 30, 2019
We often forget the importance that language plays with regards to our own and others’ mental health. The words that we choose to use, even if they are synonyms of others, may reflect a bias, negativity or something else: To ourselves and to each other.
Blog October 29, 2019
In an effort to fight atrial fibrillation (AFib), Pfizer and Bristol-Myers Squibb are banding together with, well, a band: Fitbit, the brand behind the popular activity-tracking wristwear that has helped fashion an entire generation of avid sleep-trackers and step-counters.
Blog October 28, 2019
Are U.S. sheriffs PhRMA’s new spokespeople? Learn why not all PR is good PR in this week’s edition of The Week That Was.
Blog October 25, 2019
In a 2017 survey conducted by Ann McKee, a neuropathologist, of 202 former football players’ brains that were donated to science, all but one suffered from Chronic Traumatic Encephalopathy.
Blog October 24, 2019
A global alliance of 17 organizations, headed up by the American College of Sports Medicine (ACSM), published a report advising doctors to prescribe exercise to cancer patients.
Blog October 21, 2019
From potential drug pricing policies to investor interest in life science companies, there’s a lot of talk around money and medicines right now. In this week’s edition of The Week That Was we discuss the current situation and what may be coming for the healthcare industry.
Blog October 18, 2019
EASD—Europe’s largest Diabetes Congress—just wrapped up. Check out 3 things you might have missed.
Blog October 14, 2019
Missed the most recent analysis conducted by ICER? The report details the “drugs whose price increases would have contributed to the largest net increase in drug spending in the US” and more. We have summed up the main takeaways and what they may mean for you.
Blog October 8, 2019
The FDA is expecting to receive more than 200 investigational new drug applications per year for gene therapies, starting in 2020. What does this mean for life science companies? Check out this week’s edition of The Week That Was.
Blog October 4, 2019
Recognizing that the impact of multiple sclerosis (MS) goes beyond the conventionally recognized symptoms, Sanofi has announced a new app to support people with the disease—specifically, their mental health.
Blog October 3, 2019
23andMe, the spit-kit DNA test company that announced a partnership with GSK last year, is embarking on a new health care foray. In partnership with the startup TrialSpark, 23andMe is going to play its part in revolutionizing clinical trials.
Blog September 30, 2019
How could the recent impeachment inquiry effect drug pricing legislation on the Hill? In this week’s edition of The Week That Was, we analyze the possible implications a presidential impeachment would have on drug pricing policy.
Blog September 26, 2019
With mental health drawing an increasing amount of attention, big brands like Starbucks are stepping up to craft a more inclusive workplace with new benefits and policies that put the health of their employees first.
Blog September 25, 2019
Over many years, studies have highlighted how mental health and behaviors affect physical health. Intertwined with this concept we’ve seen new frontiers with behavioral economics, including motivational behavior, navigating biases and irrational behavior.
Blog September 23, 2019
From Sen. Nancy Pelosi’s highly anticipated drug pricing plan to risk-adverse investors, our team shares the latest on the healthcare environment in this week’s edition of The Week That Was.
Already have a RSS feed reader?
